We report the isolation and characterization of a cDNA encoding Dm2-MMP, the second matrix metalloproteinase (MMP) identified in the Drosophila melanogaster genome. The cloned cDNA codes for a polypeptide of 758 residues that displays a domain organization similar to that of other MMPs, including signal peptide, propeptide, catalytic, and hemopexin domains. However, the structure of Dm2-MMP is unique because of the presence of an insertion of 214 amino acids between the catalytic and hemopexin domains that is not present in any of the previously described MMPs. Dm2-MMP also contains a C-terminal extension predicted to form a cleavable glycosylphosphatidylinositol anchor site. Western blot and immunofluorescence analysis of S2 cells transfected with the isolated cDNA confirmed that Dm2-MMP is localized at the cell surface. Production of the catalytic domain of Dm2-MMP in Escherichia coli and analysis of its enzymatic activity revealed that this proteinase cleaves several synthetic peptides used for analysis of vertebrate MMPs. This proteolytic activity was abolished by MMP inhibitors such as BB-94, confirming that the isolated cDNA codes for an enzymatically active metalloproteinase. Reverse transcription-PCR analysis showed that Dm2-MMP is expressed at low levels in all of the developmental stages of Drosophila as well as in adult flies. However, detailed in situ hybridization at the larval stage revealed a strong tissue-specific expression in discrete regions of the brain and eye imaginal discs. According to these results, we propose that Dm2-MMP plays both general proteolytic functions during Drosophila development and in adult tissues and specific roles in eye development and neural tissues through the degradation and remodeling of the extracellular matrix.
The matrix metalloproteinases (MMPs) 1 are a family of structurally related enzymes that play major roles in the connective tissue remodeling occurring in a variety of physiological conditions, such as embryonic growth and development, angiogenesis, wound healing, or reproductive processes (1) (2) (3) . In addition, deregulated production of these endopeptidases is associated with a number of pathological conditions including rheumatoid arthritis (4), atherosclerosis (5) , and tumor invasion and metastasis (6) . To date, more than 20 distinct MMPs have been identified in human tissues (7) (8) (9) . These MMPs have been classified into six major subfamilies according to their primary structures, domain organization, cellular localization, and substrate specificity. These subfamilies are collagenases, stromelysins, gelatinases, matrilysins, membrane-type MMPs, and other MMPs (9) . The structure of most of these enzymes is organized into several characteristic domains: a signal peptide to direct secretion from the cell, a prodomain with a conserved Cys residue involved in maintaining the enzyme latency, a catalytic domain with a zinc-binding site, and a hemopexin-like domain that plays a role in substrate binding as well as in mediating interactions with the tissue inhibitors of metalloproteinases (TIMPs), a family of endogenous inhibitors of MMPs (10) . Several members of the human MMP family lack some of these well defined domains. Thus, MMP-23, the most distantly related family member, does not contain a cleavable signal peptide (11, 12) , whereas matrilysins have lost the hemopexin domain (9) . In contrast, additional domains such as fibronectinlike repeats or C-terminal hydrophobic extensions have been incorporated into the structure of other family members like gelatinases or membrane-type MMPs, thereby contributing to generate a considerable diversity in the structural organization of these enzymes.
In close parallelism with the structural complexity of MMPs, recent functional studies have revealed that these proteinases are also involved in processes distinct from those derived from their ability to degrade the different protein components of the extracellular matrix and basement membranes. Thus, MMPs play direct roles in essential cellular processes such as proliferation, differentiation, angiogenesis, apoptosis, or defense responses through their ability to target other substrates including proteinase inhibitors, chemokines, antimicrobial peptides, and membrane-bound precursors of growth factors, cytokines, and hormone receptors (13) (14) (15) (16) (17) (18) ).
An important aspect in understanding the increased functional diversity of this growing family of proteolytic enzymes is to identify and characterize MMPs in model organisms, in which the functional relevance of these enzymes can be extensively analyzed by using distinct experimental strategies. Thus, in addition to the diverse MMPs identified in vertebrates, proteases belonging to this family have also been described in a variety of organisms from plants such as Arabidopsis thaliana (19) , soybean (20) , and cucumber (21) , to invertebrates like Caenorhabditis elegans (22) , sea urchin (23), Hydra vulgaris (24) , and more recently Drosophila melanogaster (25) . In this regard, we have described the finding and characterization of Dm1-MMP, the first member of this proteinase family identified in Drosophila (25) , a model organism that is central to the study of developmental biology. Because of the relevance of MMPs in developmental processes, the finding of additional members of this family in Drosophila may contribute to uncover new substrates and new functions for these enzymes, potentially extrapolable to vertebrate MMPs. In this study, we report the cloning and the structural and enzymatic characterization of Dm2-MMP, the second member of the MMP family identified in D. melanogaster. Interestingly, extensive searches of the Drosophila genome revealed the presence of only two MMPs in this organism, thus offering a simplified and genetically tractable system to study MMP function in development. We have also performed an expression analysis of Dm2-MMP during Drosophila development, showing that the gene is expressed at all stages. Detailed in situ hybridization analysis at the larval stage revealed a strong expression in discrete regions of the brain and eye imaginal discs. Taken together, our data suggest that this novel MMP member may play both general and specific degradative roles in the extracellular matrix remodeling processes occurring in Drosophila during development and in adult tissues.
EXPERIMENTAL PROCEDURES
Materials-Synthetic oligonucleotides were prepared with an Applied Biosystems (Foster City, CA) model 392A DNA synthesizer. Restriction endonucleases and reagents used for molecular cloning were from Roche Molecular Biochemicals. Double-stranded DNA probes were radiolabeled with [ 32 P]dCTP (3000 Ci/mmol) from Amersham Biosciences, using a commercial random priming kit from the same company.
Probe Preparation and Hybridization of a Drosophila cDNA Library-Screening of the GenBank TM data base for entries with similarity to previously described MMPs allowed us to identify a sequence (AC005894) contributed by the Berkeley Drosophila Genome Project. This sequence revealed regions with significant similarity to the catalytic and hemopexin domains of MMPs. To obtain the corresponding cDNA sequence, two specific primers 5Ј-TGCAGACCGCCCTGGACGT (primer 1, catalytic domain) and 5Ј-ATGTAGGTGCGGTTGTTGTGG (primer 2, hemopexin domain) were used for PCR amplification to prepare a probe for screening of cDNAs from different developmental stages. The PCR reaction was carried out in a GeneAmp 2400 PCR system from PerkinElmer Life Sciences for 30 cycles of denaturation (94°C for 15 s), annealing (60°C for 15 s), and extension (72°C for 45 s). A 1473-bp PCR product amplified from pupa cDNA was radiolabeled and used to screen a pupa cDNA library according to standard procedures (26) . In addition, we obtained a 4120-bp full-length cDNA (SD03462) identified by the Berkeley Drosophila Genome Project (Research Genetics). Cloned DNA fragments were sequenced with an Applied Biosystems 310A automatic sequencer (PerkinElmer Life Sciences). Computer analysis of DNA and protein sequences was performed with the GCG software package of the University of Wisconsin Genetics Computer Group.
Construction of an Eukaryotic Expression Vector for Dm2-MMP and Immunolocalization-Full-length Dm2-MMP cDNA was subcloned into pRmHA-3 expression vector (27) . In addition, a 24-bp linker coding for the hemagglutinin (HA) epitope of the human influenza virus was inserted immediately downstream of the putative furin cleavage motif. S2 cells were transfected with 1 g of plasmid DNA, using the FuGENE 6 reagent (Roche Molecular Biochemicals) according to the manufacturer's instructions. Forty-eight hours after transfection, CuSO 4 was added to a final concentration of 0.7 mM to induce the cells and incubated for 6 -18 h to produce the protein. The cells were then fixed for 10 min in cold 4% paraformaldehyde in PBS, washed in PBS, and incubated for 10 min in the presence or absence of 0.2% Triton X-100 in PBS. Fluorescent detection was performed by incubating the slides with monoclonal antibody 12CA5 (Roche Applied Science) against HA (diluted 1:2500), followed by another incubation with goat anti-mouse fluoresceinated antibody (diluted 1:50). After washing in PBS, the slides were mounted with Vectashield (Vector Laboratories, Burlingame, CA) and observed in a Bio-Rad confocal laser microscope. S2 extracts were also obtained for Western blot analysis of the Dm2-MMP-HA protein.
Preparation of Cell Membrane Fractions and Western Blot Analysis-S2 cells were transiently transfected with the pRmHA-3-Dm2-MMP-HA plasmid as described previously. The cells were scraped from the plates, and the membrane fractions were prepared essentially following the procedure described by Strongin et al. (28) . The extracts were separated by SDS-PAGE, analyzed by Western blotting with an anti-HA monoclonal antibody, and detected with an enhanced chemiluminescence kit (Amersham Biosciences).
Production of Recombinant Dm2-MMP in Escherichia coli-A 462-bp fragment of the Dm2-MMP cDNA containing the catalytic domain was generated by PCR amplification with primers 5Ј-GGAATTCCATATGT-TCGCCCTGCAGGGACCCAAG (NdeI-proDm2) and 5Ј-CGGGATCCT-TAGTACAACTGCTGAATGCCATA (BamHI-proDm2) using the fulllength Dm2-MMP cDNA as a template. PCR amplification was performed for 30 cycles using the Expand TM high fidelity PCR system. Because of the design of the oligonucleotides, the amplified fragment could be cleaved at both ends with NdeI and BamHI and ligated in frame into the pET E. coli expression vector (Novagen). The resulting pET-Dm2 vector was transformed into BL21(DE3) E. coli cells, and expression was induced by the addition of isopropyl-1-thio-␤-D-galactopyranoside (final concentration, 0.5 mM) followed by further incubation for 20 h at 30°C. Recombinant protein obtained in inclusion bodies was solubilized using 20 mM Tris buffer, pH 7.6, containing 6 M GdnHCl and 5 mM dithiothreitol and purified in a Superdex-75 column (Amersham Biosciences) equilibrated with 20 mM Tris buffer, pH 7.6, containing 3 M GdnHCl and 5 mM dithiothreitol. After SDS-PAGE analysis, peak fractions with the recombinant protein were pooled, and the GdnHCl concentration was adjusted to 6 M. Refolding was achieved by dialysis, first against a 50 mM Tris buffer, pH 7.6, containing 5 mM CaCl 2 , 200 mM NaCl, 50 M ZnSO 4 , 0.05% Brij 35, 20% glycerol, and 2 M GdnHCl and then against the same buffer with 2 mM dithiothreitol and without GdnHCl.
Enzymatic Assays-Enzymatic activity of purified recombinant Dm2-MMP was analyzed by using the synthetic fluorescent substrates Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 (QF-24), Mca-Pro-Leu-AlaNva-Dpa-Ala-Arg-NH 2 (QF-35), and Mca-Pro-Cha-Gly-Nva-His-AlaDpa-NH 2 (QF-41) (provided by C. G. Knight, University of Cambridge, Cambridge, UK). The assays were performed at 37°C at substrate concentrations of 1 M in a buffer containing 50 mM Tris/HCl, 5 mM CaCl 2 , 200 mM NaCl, 0.05% (v/v) Brij 35, pH 7.6, and 1% Me 2 SO (29). For inhibition assays, Dm2-MMP (20 nM) and inhibitors were preincubated for 30 min at 20°C, with 1 mM EDTA or with BB-94 (BritishBiotech Pharmaceuticals, Oxford, UK) at concentrations ranging from 0 to 100 nM. The fluorometric measurements were made in an MPF-44A PerkinElmer Life Sciences spectrofluorometer ( ex ϭ 328 nm, em ϭ 393 nm). Homology Modeling-A three-dimensional model of the catalytic domain of Dm2-MMP was calculated using Swiss-Model, a semiautomated modeling server (30) , and analyzed with the Swiss Protein Data Bank Viewer. The quality of the resulting models was verified automatically with WhatCheck and manually with the Swiss Protein Data Bank Viewer. Electrostatic analyses of the model were performed with MolMol (31) .
RT-PCR Analysis-RT-PCR was performed for analysis of Dm2-MMP expression during Drosophila development or in adult flies. Total RNA was extracted from diverse developmental stages of Drosophila or from adult tissues, and 1 g was used to perform the reverse transcription. The PCR reaction was carried out for 35 cycles of denaturation (94°C for 15 s), annealing (60°C for 15 s), and extension (72°C for 25 s) using two specific oligonucleotides 5Ј-TTACCTCATGCAGTTTGAT-TATCT (primer 1), and 5Ј-CTCCACGTAAGATCCGTTCTG (primer 2). The integrity of RNA was verified by similar RT-PCR experiments using specific primers for the Drosophila gene encoding ribosomal protein 49 (rp-49).
In Situ Hybridization-RNA in situ analysis was performed as described previously (32) 
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tions were carried out overnight at 55°C, and the alkaline phosphatase detection buffer was prepared from Sigma Fast TM 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets instead of Tris/HCl. Digoxigenin-labeled RNA probes made from cDNA SD04362 were prepared according to the protocol described for the Genius system (Roche Molecular Biochemicals).
RESULTS

Molecular Cloning and Structural Characterization of a Drosophila cDNA Coding for a Matrix
Metalloproteinase-A computer search of the data base of Drosophila genomic sequences allowed us to identify a sequence (AC005894) that contains a region with significant similarity to the catalytic and hemopexin domains found in most vertebrate MMPs. To define the precise structure of this putative novel fly MMP, we undertook the isolation of a cDNA encoding this protein. First, we prepared a specific probe for this enzyme by PCR amplification of total -phage DNA obtained from a fly pupa cDNA library. The identity of the PCR-amplified product was confirmed by nucleotide sequencing, and then it was used as a probe to isolate a 3.4-kb cDNA clone from the same fly pupa gt-11 library. The sequence of this clone was subsequently confirmed and extended by nucleotide sequence analysis of a 4120-bp cDNA clone (SD03462) obtained from the Berkeley Drosophila Genome Project and isolated from a Schneider L2 cell cDNA library. Computer analysis of the 3.4-and 4.1-kb cDNA isolated sequences revealed the presence of a unique open reading frame that encodes a protein of 758 residues with a calculated molecular mass of 89 kDa (Fig. 1) . These sequences would be encoded by one of the annotated genes (CG1794, located in region 45F6 -46A1) in the Drosophila genome sequence recently reported (33) . Nevertheless, there are several differences in the number and location of computer-predicted exons for CG1794, when compared with the experimental data derived from the cDNA sequences reported herein (Fig. 1) . In addition, pairwise comparisons of the protein sequence derived in this work with those described previously for other MMPs demonstrated that the new sequence contains all the structural features present in members of this protease family (Fig. 2A) . From N terminus to C terminus, it includes a predicted Nterminal cleavable signal peptide that targets these proteolytic enzymes to the secretory pathway. The deduced sequence also contains a propeptide region with the conserved motif PRCGVXD (at positions 106 -112), which is involved in maintaining the latency of these proteinases. This prodomain ends in a stretch of basic amino acid residues (RVRR, at positions 133-136) that mediates the intracellular activation of several MMPs including membrane-type MMPs, stromelysin-3, and MMP-28 by furin-like enzymes (7, 8, 34, 35) .
The sequence alignment shown in Fig. 2B also confirms the presence in the Drosophila MMP sequence of a catalytic domain of about 170 residues, containing the zinc-binding site (HEXGHXXGXXH, at positions 257-267) and the Ser residue (position 268) that distinguishes MMPs from other metalloproteinases. There is also a conserved Met residue located seven residues C-terminal to the zinc-binding site that is proposed to play an important role in the structure of the MMPs active sites (36) . Finally, the identified sequence contains a C-terminal fragment of about 200 residues similar to the hemopexin-like domain found in most MMPs. According to these structural features, we suggest that the cloned cDNA encodes a new MMP family member that has been named Dm2-MMP, because it is the second MMP identified and characterized in D. melanogaster.
A more detailed analysis of the amino acid sequence deduced for Dm2-MMP revealed that in addition to common features shared with MMPs, it also shows some specific features unique to this protein ( Fig. 2A) . Thus, it contains an insertion of about 200 amino acids in the hinge region located between the catalytic and hemopexin domains (at positions 308 -509). This insertion is not present in the sequence of Dm1-MMP or in those reported for the remaining members of this family. In this extra domain found in Dm2-MMP, there is a long stretch of Thr residues and multiple repeats of a seven-amino acid sequence containing Glu, Gln, and Arg residues (RQEEERR, or variants of this sequence). It is also remarkable that Dm2-MMP lacks 
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conserved residues characteristic of collagenases or stromelysins (37, 38) , as well as the fibronectin-like domain present in all gelatinases. Interestingly, Dm2-MMP possesses a C-terminal extension rich in acidic residues and ending in a stretch of hydrophobic residues that is predicted to form a cleavable glycosylphosphatidylinositol anchor site (program available at 129.194.186.123/GPI-anchor/index_en.html). Therefore, it is likely that Dm2-MMP belongs to the subfamily of membranetype MMPs structurally characterized by having a hydrophobic region at the C-terminal end as well as by the presence of the furin-like activation sequence between the propeptide and the catalytic domain (39 -42) . The intron-exon distribution of the gene encoding Dm2-MMP is also somewhat similar to that of some vertebrate MMPs, such as MMP-28 and MT6-MMP, and markedly different from that of Dm1-MMP (Fig. 3) .
Membrane Localization of Dm2-MMP-To provide experimental support to the above hypothesis on the putative membrane localization of Dm2-MMP, we transfected S2 cells with pRmHa-3-Dm2-MMP-HA, a construct containing the HA epitope immediately downstream of the furin-like cleavage motif present in the amino acid sequence deduced for Dm2-MMP. Transfected cells were then analyzed by Western blot with a mouse monoclonal antibody (12CA5) specific for this viral epitope. As shown in Fig. 4A , Dm2-MMP was detected in the membrane-enriched fractions but not in the soluble fraction. To provide additional information on the subcellular distribution of Dm2-MMP, we transfected S2 cells with the pRmHa-3-Dm2-MMP-HA construct, and transfected cells were then analyzed by immunofluorescence with the 12CA5 antibody. As shown in Fig. 4B , a fluorescent pattern surrounding the cell was clearly visualized in a serial optical section obtained by the confocal microscope. Taken together, these results provide experimental evidence that Dm2-MMP is a member of the membranetype MMP subfamily of MMPs.
Analysis of the Enzymatic Activity of Recombinant Dm2-MMP-After the preceding findings showing that Dm2-MMP was structurally related to MMPs, we next evaluated the possibility that this protein could be a functionally active member of this proteinase family. For this purpose, a cDNA construct coding for the Dm2-MMP catalytic domain was expressed in E. coli following the same strategy described previously for Dm1-MMP (25) (Fig. 5) . To assess the substrate specificity of the recombinant protease, a series of quenched fluorescent peptides commonly used for assaying vertebrate MMPs were employed. As shown in Fig. 6 , the general MMP substrate QF-24, the collagenase/gelatinase substrate QF-41, and the stromelysin substrate QF-35 were hydrolyzed by Dm2-MMP. Next, we examined the potential inhibition of active Dm2-MMP by EDTA and the hydroxamic acid-based inhibitor BB-94, using QF-24 as substrate. As can be seen in Fig. 6 , EDTA completely abolished the hydrolyzing activity of Dm2-MMP, whereas BB-94 extensively blocked this proteolytic activity.
Homology Modeling of the Catalytic Domain of Dm2-MMPThe amino acid sequence determined for Dm2-MMP is similar to several vertebrate MMPs of known three-dimensional structure, thus opening the possibility of creating a computer model of the structure of this Drosophila enzyme, especially in terms of the size of its S1Ј pocket, an essential specificity determinant in MMPs. The depth of this pocket is largely determined by the residue located at position 214 (MMP-1 numbering) (43) (44) (45) (46) (47) . MMPs with small residues at that key position show a channel across the protease structure, allowing the cleavage of substrates with bulky P1Ј side chains. By contrast, MMPs with large residues at position 214 occlude the S1Ј channel and leave a cavity that can only accept middle sized substrates. The predicted structure of Dm2-MMP with an Asn residue at the equivalent position (Asn-253) reveals a large and open S1Ј pocket (data not shown), thereby predicting that this enzyme may accommodate bulky residues in this site.
Expression Pattern of Dm2-MMP-To determine the temporal expression pattern of Dm2-MMP during Drosophila development, we performed RT-PCR of total RNA prepared from different developmental stages and adult flies. As can be seen in Fig. 7A , Dm2-MMP is detected in all of the developmental stages tested as well as in male and female adult flies. However, Dm2-MMP transcripts could not be detected by standard Northern blot assays, indicating that it is expressed at low levels or in few specific cells. To get information on the temporal and spatial pattern expression of Dm2-MMP, we performed whole mount in situ hybridization to third instar larvae. As shown in Fig. 7 (B-E) , expression is restricted to specific domains, indicating that Dm2-MMP has tissue-specific functions. Hybridization to eye imaginal discs reveals a strong staining behind the morphogenetic furrow, a region where photoreceptors are formed during larval development. In the brain, expression is strong in the optic lobe region, where photoreceptors 
project their axons. Altogether, these data suggest a role for Dm2-MMP in eye and nervous system formation.
DISCUSSION
This work describes the cloning and characterization of the second MMP identified in D. melanogaster. The strategy used to clone Dm2-MMP was based on the search for structural motifs of vertebrate MMPs in Drosophila genomic sequences, followed by hybridization of a Drosophila cDNA library with a probe derived from a MMP-related sequence identified in the fly genome. This approach allowed us to isolate a full-length cDNA coding for a protein that contains all structural domains characteristic of MMPs, including the signal peptide, the prodomain, the catalytic domain, the hinge region, and the C-terminal hemopexin domain. In addition, the recombinant protein produced in E. coli is able to degrade several peptides widely used as substrates for vertebrate MMPs, and this proteolytic activity is abolished by MMP inhibitors. According to these structural and enzymatic properties, we conclude that the identified cDNA codes for a functionally active member of the MMP family that we called Dm2-MMP. Nevertheless, the sequence of Dm2-MMP is unique because of the presence of an insertion of 200 amino acids in the hinge region located between the catalytic and hemopexin domains. This sequence is not present in Dm1-MMP or in other MMPs from different sources. The functional significance of this domain characteristic of Dm2-MMP is presently unknown, although it could serve to mediate interactions with other proteins, including the putative substrates of this enzyme.
The structural differences between the two MMPs identified in Drosophila can be also extended to their respective expression patterns. Thus, Dm2-MMP is expressed, albeit at low levels, in all of the developmental stages of Drosophila, as well as in male and female adult flies. By contrast, Dm1-MMP is strongly expressed in the developing embryo at stages 12 and 13, declining thereafter and being almost undetectable in adult flies (25) . These differences in the expression patterns of the two MMPs present in Drosophila are consistent with the possibility that both enzymes play distinct roles in the tissue remodeling processes occurring during fly development. Interestingly, Dm2-MMP is expressed in discrete regions of the nervous system both in embryos (data not shown) and larvae, suggesting a specific role of this enzyme in this tissue. Dm2-MMP proteolytic activity on the extracellular matrix may play an important role in photoreceptors growth cone guidance and/or cell rearrangement in the retina and nervous system. In this respect, it is interesting to note that some MMPs are found to be associated with extending neurites and play important roles in growth cones in mammals (48 -50) . The different substrate specificities of Dm1-MMP and Dm2-MMP, as assayed using synthetic substrates, together with the nonoverlapping patterns of MMP expression, suggest distinct roles for Dm1-MMP and Dm2-MMP in development. Further comparative genetic loss-and gain-of-function studies will provide cues on the cellular role of each MMP in Drosophila. In any case, it is remarkable that seemingly, only two MMPs are necessary in Drosophila to accomplish the extensive matrix remodeling required during embryonic and larval development, metamorphosis, and adult life. In fact, after exhaustive screening of the Drosophila genome, we have not found any evidence of the presence of additional MMP genes other than those encoding Dm1-MMP, and Dm2-MMP. Nevertheless, it is very interesting that one of these MMPs (Dm1-MMP) seems to be a secreted protease, whereas Dm2-MMP is membrane-bound, thereby providing a further level of versatility in the type of substrates that can be targeted by these two enzymes. On the other hand, it is remarkable that we have not found other Drosophila TIMP genes distinct from that recently described by Pohar et al. (51) . Therefore, we conclude that the Drosophila MMP proteolytic system is complete in terms of presence of both proteases and inhibitors with the ability to mediate and modulate tissue remodeling processes in this organism but extremely simple when compared with the MMP system operating in verte- FIG. 7 . Expression analysis of Dm2-MMP in diverse Drosophila development stages. A, the presence of Dm2-MMP transcripts during development was determined by RT-PCR, using total RNA extracts prepared from different stages. Amplification of ribosomal protein 49 was used as a control for RNA integrity. B-E, whole mount in situ hybridization to third instar larvae using a Dm2-MMP antisense RNA probe. Expression of Dm2-MMP is detected in the optic lobe (B and C) in the brain and in imaginal discs (D and E). C corresponds to a close up of the optic lobe, in which expression is detected in the lamina. In eye imaginal discs (B and D), expression is strong behind the morphogenetic furrow where photoreceptors form. In wing imaginal discs (E), expression is weak and diffuse. No signal was detected with a control sense probe.
brates. Thus, to date 24 MMP genes and four TIMP genes have been identified in the human genome (7-10, 52), indicating that these protease and inhibitor families have undergone extensive gene duplication events after the divergence of vertebrates and invertebrates.
At present we can only speculate on why Drosophila has only two MMPs in its genome, whereas humans or other organisms, including C. elegans, have many more members of this protease family (52) . It has been proposed that this fact could reflect the different developmental processes occurring in these organisms (53) . Thus, in vertebrates and nematodes, growth and development involve extensive cell migration and rearrangement, whereas Drosophila undergoes an early syncytial stage prior to cellularization. The low number of MMPs in Drosophila could therefore indicate that cell release from the extracellular matrix is a generic requirement in this organism, whereas the complex matrix-remodeling processes taking place in the other organisms involve more specific and highly regulated functions and, consequently, a higher number of proteolytic enzymes potentially associated with them. On this basis, it has been suggested that Drosophila may not be a good model to study specific processes associated with these MMP functions (53) . However, we consider that the simple comparison of the number of MMP genes with the fact that Drosophila undergoes an early syncytial stage should not be used to get definitive conclusions regarding the functional relevance of the MMP system in this organism or its value as a model for extrapolating MMP functions to other organisms. Thus, the syncytial stage lasts just for the first 2 h of Drosophila development, in the absence of zygotic transcription, whereas full Drosophila development takes 11 days at 25°C. Furthermore, Drosophila, like any other multicellular organism, undergoes several crucial developmental processes involving cell rearrangements and migration, as well as wound healing (54, 55) . On the other hand, behind the apparent simplicity of the MMP system in Drosophila, it may be possible to uncover new mechanisms controlling MMP expression or function of potential relevance to vertebrate MMPs. Likewise, the limited number of endogenous enzymes in Drosophila as compared with human may represent a unique system to study vertebrate MMPs in gain-of-function studies through expression of heterologous proteases in flies, without interfering with the Drosophila endogenous system. Finally, we must consider that the high number of MMPs in vertebrates may also reflect a significant degree of redundancy in this system, a possibility that is consistent with the lack of significant abnormalities in most mutant mice deficient in specific MMPs (56) . In summary, and despite some caveats, we believe that the simplified MMP-TIMP system from Drosophila, whose description is now completed with the finding of Dm2-MMP, may be an advantageous model for studying the role of protease-mediated events during development processes. Consistent with this proposal, recent studies in this organism have established the relevance of diverse proteases, including metalloproteinases like Kuzbanian, Tolloid, and Tolkin, in signaling pathways operating in essential processes such as neurogenesis or embryonic patterning (57) (58) (59) (60) (61) .
In summary, we have cloned and characterized Dm2-MMP, the second member of the MMP family identified in D. melanogaster. This enzyme exhibits structural and functional similarities with Dm1-MMP as well as with vertebrate MMPs, in terms of similar domain organization, profile of activity against synthetic substrates, and sensitivity to inhibitors. However, Dm2-MMP also exhibits unique features including an extremely long hinge region that distinguishes this enzyme from all the remaining MMPs described in any organism. In addition, the predicted architecture of the catalytic domain of Dm2-MMP, with an unusually large and open S1Ј pocket, supports the proposal that this protease may have a wide substrate specificity. Further biochemical studies, together with genetic analysis of mutant flies deficient in Dm2-MMP, will be required to identify the relevant in vivo substrates of this protease and to define its precise role in any of the extensive extracellular matrix remodeling processes taking place during Drosophila development.
